FOLH1 and neoplasm: <i>In vivo</i> PET studies showed specificity of [<sup>43</sup>Sc]Sc-PSMA-617 while SPECT studies demonstrated tumor retention of [<sup>47</sup>Sc]Sc-PSMA-617 up to 48 h.